Profusa, Inc.

Profusa, Inc. (Nasdaq: PFSA) is a San Francisco-based medical technology company specializing in biologically integrated, implantable biosensors designed for continuous, real-time monitoring of physiological chemistry, including oxygen and metabolic markers. The company completed its transition to the public markets through a special purpose acquisition company transaction and operates in the healthcare and medical devices sector, where it competes alongside other continuous biosensing and digital health platforms. The 8-K filing dated September 1, 2026, with accession number 0001213900-26-095984, represents a current report submitted to the Securities and Exchange Commission disclosing a material event. Investors and researchers seeking full SPAC deal terms, sponsor details, and ongoing corporate disclosures for PFSA can access comprehensive data by signing up at SpacDesk.